Edition:
United States

Lonza Group AG (LZAGF.PK)

LZAGF.PK on OTC Markets Group

265.50USD
11:15am EDT
Change (% chg)

$1.75 (+0.66%)
Prev Close
$263.75
Open
$265.50
Day's High
$265.50
Day's Low
$265.50
Volume
1
Avg. Vol
78
52-wk High
$265.50
52-wk Low
$166.15

Select another date:

Wed, Jul 26 2017

UPDATE 2-Lonza outlines 2022 targets, shares hit record highs

ZURICH, July 26 Swiss pharmaceutical supplier Lonza Group AG set out ambitious growth targets and beat market expectations for first-half core profit, sending its shares more than 6 percent higher on Wednesday.

Lonza confirms 2017 outlook, outlines new 2022 targets

ZURICH, July 26 Swiss pharmaceutical supplier Lonza Group AG on Wednesday confirmed its 2017 outlook and outlined new targets through to 2022.

BRIEF-Lonza H1 sales 15.1 percent up to CHF 2,323 million

* Lonza delivers strong performance in first half 2017 and sets a strong foundation for continued attractive mid-term growth

BRIEF-Lonza says received regulatory approval for Capsugel acquisition

* Says lonza has received all regulatory approvals to move forward with acquisition of Capsugel

BRIEF-Lonza aims to raise 2.25 billion Sfr with new rights offering

* Says determined the final terms of the capital increase by way of a rights offering

Lonza to seek shareholder sign-off on 2.3 billion Sfr rights issue

ZURICH Lonza Group AG will ask shareholders at next month's annual general meeting for permission to issue up to 2.3 billion Swiss francs ($2.3 billion) in new shares to finance its acquisition of U.S. capsule maker Capsugel, the Swiss pharmaceutical supplier said on Thursday.

Lonza to seek shareholder sign-off on 2.3 bln Sfr rights issue

ZURICH, March 30 Lonza Group AG will ask shareholders at next month's annual general meeting for permission to issue up to 2.3 billion Swiss francs ($2.3 billion) in new shares to finance its acquisition of U.S. capsule maker Capsugel, the Swiss pharmaceutical supplier said on Thursday.

Select another date: